Notice ID: 649cdc32e3ab4fd791566e2135050a49PresolicitationArchived
Modification to the A11 HERV-E TCR and T cell product to improve the therapeutic efficacy for ccRCC patients.
Archived on June 4, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 9:00 AM EDT
- Posted
- May 19, 2026
- Notice type
- Presolicitation
- Set-aside
- No Set aside used
- NAICS
- 622110: General Medical and Surgical Hospitals
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH OLAO
- Place of performance
- Bethesda, Maryland, 20892
- Last updated
- Oct 30, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 75N98026Q00392
- Notice ID
- 649cdc32e3ab4fd791566e2135050a49
Description
Attachment: Notice of Intent to Sole Source
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
FALZONE, MICHAEL L
Documents
Files (1)
- Download
Notice of Intent to Sole Source.pdf
206 KBAdded in Presolicitation version 3Posted
Lifecycle
- 3Version 3PresolicitationArchivedCurrent
Modification to the A11 HERV-E TCR and T cell product to improve the therapeutic efficacy for ccRCC patients.
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N98026Q00392
Archive Date
Jun 4, 2026
Office Address
BETHESDA, MD, 20892